Part four of our webinar series on liquid biopsies:
Circulating cell-free DNA purification, sequencing and data interpretation
Identification and monitoring of cancer mutations of circulating cell-free DNA (cfDNA) is a key application in liquid biopsy. In the webinar series, we discuss various new technologies and present a complete sample to insight workflow for cfDNA mutation analysis. In this webinar, we show how mutations can be best identified from this type of data and how they can be interpreted. Anika Joecker, Global Solution Product Manager Bioinformatics, Clinical Program, present our solutions for analysis and interpretation of cell free DNA.
